Sentiment: Strong Buy
who da f would want to buy an inferior product to Vascepa? OMTH will probably go to $0 in the next year
I say let OMTH hit the roof. It would only make sense that AMRN with a superior ALREADY APPROVED AND ON THE MARKET drug would be celestial in comparison.
under $1 within a year.
GET IN NOW